Showing results (241-250 of 528) with videos related to
Sort By:
Pageof 53
Medical Education|February 3, 2006
Setting school-level outcome standardsDavid T Stern, Miriam Friedman Ben-David, John Norcini, et al.Plos One|October 28, 2014
Mutations at beta N265 in γ-aminobutyric acid type A receptors alter both binding affinity and efficacy of potent anestheticsDeirdre S Stewart, David W Pierce, Mayo Hotta, et al.Methods in Molecular Biology (Clifton, N.J.)|October 18, 2017
Assessing NLRP3 Inflammasome Activation by NanoparticlesBhawna Sharma, Christopher B McLeland, Timothy M Potter, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 6, 2006
Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasmaZhiming Wen, Stephan T Stern, David E Martin, et al.The American Journal of Gastroenterology|June 1, 1993
Atypical arthropathy associated with Crohn's diseaseK I Norton, A H Eichenfield, J R Rosh, et al.Thrombosis and Haemostasis|October 1, 1981
Coagulation and fibrinolysis study in systemic lupus erythematosus: haematological, urinary and tissue parametersP Stratta, C Canavese, P Valmaggia, et al.The American Journal of Pathology|October 9, 1999
A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1)W Pfeifer, E Levi, T Petrogiannis-Haliotis, et al.Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1E Levi, R Fridman, H Q Miao, et al.Journal of Submicroscopic Cytology and Pathology|April 1, 1988
Morphologic evidence that disruption of the Golgi apparatus in PFHR 9-tumor cells causes disturbance in the traffic through this organelleL C Junqueira, R Kaminskas, J E Levi, et al.Blood|October 9, 1999
A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphomaW P Schiemann, W M Pfeifer, E Levi, et al.Pageof 53